These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10646862)

  • 1. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity.
    Fujii H; Yoshida M; Gong ZX; Matsumoto T; Hamano Y; Fukunaga M; Hruban RH; Gabrielson E; Shirai T
    Cancer Res; 2000 Jan; 60(1):114-20. PubMed ID: 10646862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic classification of combined hepatocellular-cholangiocarcinoma.
    Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
    Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma.
    Matsumoto T; Fujii H; Arakawa A; Yamasaki S; Sonoue H; Hattori K; Kajiyama Y; Hirose S; Tsurumaru M
    Hum Pathol; 2004 Mar; 35(3):322-7. PubMed ID: 15017588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.
    Arakawa A; Fujii H; Matsumoto T; Hirai S; Suda K
    Hum Pathol; 2004 Apr; 35(4):418-23. PubMed ID: 15116321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
    Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
    Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic mucinous cystic neoplasms with sarcomatous stroma: molecular evidence for monoclonal origin with subsequent divergence of the epithelial and sarcomatous components.
    van den Berg W; Tascilar M; Offerhaus GJ; Albores-Saavedra J; Wenig BM; Hruban RH; Gabrielson E
    Mod Pathol; 2000 Jan; 13(1):86-91. PubMed ID: 10658914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinosarcoma of the uterus: immunohistochemical and genetic analysis of clonality of one case.
    Watanabe M; Shimizu K; Kato H; Imai H; Nakano H; Sugawa M; Shiraishi T
    Gynecol Oncol; 2001 Sep; 82(3):563-7. PubMed ID: 11520156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic divergence in the clonal evolution of breast cancer.
    Fujii H; Marsh C; Cairns P; Sidransky D; Gabrielson E
    Cancer Res; 1996 Apr; 56(7):1493-7. PubMed ID: 8603391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic losses at 8p, 10q, 11p, 13q, 16q, 17p, and 18q in prostatic carcinomas: The impact of zonal location, Gleason grade, and tumour multifocality.
    Erbersdobler A; Graefen M; Wullbrand A; Hammerer P; Henke RP
    Prostate Cancer Prostatic Dis; 1999 Jul; 2(4):204-210. PubMed ID: 12496779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis.
    Jin Z; Ogata S; Tamura G; Katayama Y; Fukase M; Yajima M; Motoyama T
    Int J Gynecol Pathol; 2003 Oct; 22(4):368-73. PubMed ID: 14501818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway.
    Yamamoto S; Tsuda H; Takano M; Hase K; Tamai S; Matsubara O
    J Pathol; 2008 Sep; 216(1):103-10. PubMed ID: 18600856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity in the clonal evolution of flat colorectal neoplasms.
    Fujii H; Ajioka Y; Kazami S; Takagaki T; Gong Zhu X; Hirose S; Watanabe H; Shirai T
    J Pathol; 2002 Jul; 197(3):298-306. PubMed ID: 12115875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdissection-based mutational genotyping of serous borderline tumors of the ovary.
    Krishnamurti U; Sasatomi E; Swalsky PA; Jones MW; Finkelstein SD
    Int J Gynecol Pathol; 2005 Jan; 24(1):56-61. PubMed ID: 15626917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
    Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
    Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
    Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
    J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract.
    Takahashi T; Habuchi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Yoshida O
    Cancer Res; 1998 Dec; 58(24):5835-41. PubMed ID: 9865743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the Disease.
    Trento M; Munari G; Carraro V; Lanza C; Salmaso R; Pizzi S; Santoro L; Chiarelli S; Dal Santo L; Nardelli GB; Saccardi C; Nicoletto O; Baldoni A; Rugge M; Fassan M
    Int J Gynecol Pathol; 2020 Jul; 39(4):305-312. PubMed ID: 31688243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
    Fujii H; Matsumoto T; Yoshida M; Furugen Y; Takagaki T; Iwabuchi K; Nakata Y; Takagi Y; Moriya T; Ohtsuji N; Ohtsuji M; Hirose S; Shirai T
    Hum Pathol; 2002 Apr; 33(4):421-8. PubMed ID: 12055677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic alterations in fallopian tube carcinoma: comparison to serous uterine and ovarian carcinomas reveals similarity suggesting likeness in molecular pathogenesis.
    Pere H; Tapper J; Seppälä M; Knuutila S; Butzow R
    Cancer Res; 1998 Oct; 58(19):4274-6. PubMed ID: 9766651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.